Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.65 USD -0.8% Market Closed
Market Cap: 204.7B USD
Have any thoughts about
Abbott Laboratories?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

20.7
Current
18.7
Median
12.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
20.7
=
Enterprise Value
210.6B USD
/
EBITDA
10.2B USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
19.4
2-Years Forward
EV/EBITDA
17.8
3-Years Forward
EV/EBITDA
16

See Also

Discover More